Shiaw-Yih Lin Selected Research

Shiaw-Yih Lin Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 07/2003
13	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2002
4	Genomic Instability 10/2017 - 04/2009
4	Triple Negative Breast Neoplasms 01/2017 - 09/2010
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 07/2003
3	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2022 - 11/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	Carcinogenesis 04/2017 - 10/2002
2	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2011 - 04/2009
2	Microcephaly 07/2009 - 10/2005
1	Spontaneous Remission 01/2022
1	Inflammatory Breast Neoplasms 01/2022
1	Disease Progression 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Infertility (Sterility) 01/2010
1	Colonic Neoplasms (Colon Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2005
6	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 04/2009
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 04/2016
5	Biological ProductsIBA 05/2021 - 08/2009
4	Phosphotransferases (Kinase)IBA 01/2021 - 04/2009
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
3	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 01/2017
2	BRCA1 ProteinIBA 10/2017 - 10/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012 - 09/2010
2	Small Interfering RNA (siRNA)IBA 09/2010 - 07/2003
2	Cyclin EIBA 09/2010 - 07/2003
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 08/2009 - 04/2009
1	urelumabIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	AntibodiesIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	InterleukinsIBA 01/2022
1	VaccinesIBA 01/2022
1	Replication Protein AIBA 10/2021
1	Checkpoint Kinase 1IBA 10/2021
1	Rad51 RecombinaseIBA 01/2021
1	adavosertibIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	ProteomeIBA 01/2020
1	Protein AggregatesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	pevonedistatIBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	olaparibIBA 01/2019
1	talazoparibIBA 01/2019
1	C-terminal binding proteinIBA 12/2018
1	CytokinesIBA 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 10/2017
1	lysophosphatidic acidIBA 04/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Axl Receptor Tyrosine KinaseIBA 01/2017
1	Poly Adenosine Diphosphate RiboseIBA 01/2017
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	tanespimycin (17AAG)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	MTOR InhibitorsIBA 04/2016
1	Estrogen ReceptorsIBA 10/2015
1	HeterochromatinIBA 01/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2013
1	AnthracyclinesIBA 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 01/2013
1	PoisonsIBA 01/2013
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2013
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2013
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2013
1	Forkhead Box Protein M1IBA 10/2012
1	Transcription Factors (Transcription Factor)IBA 10/2012
1	Free RadicalsIBA 02/2012
1	Histones (Histone)IBA 10/2011
1	Protein Isoforms (Isoforms)IBA 09/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2009
1	A-Form DNA (A-DNA)IBA 10/2005
1	beta CateninIBA 10/2002
1	NF-kappa B (NF-kB)IBA 10/2002

Therapy/Procedure

10	Therapeutics 06/2021 - 04/2009
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2011
3	Immunotherapy 01/2022 - 01/2018
1	Precision Medicine 04/2017
1	Isogeneic Transplantation 04/2017
1	Radiotherapy 02/2011